S. Parthé

Inhibition of leukotriene ω-oxidation by isonicotinic acid hydrazide (isoniazid)

W. Hagmann, S. Parthé, 1990 .

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

N. Halama, L. Bullinger, R. Schlenk, 2022, Nature Cancer.

Local emergence and decline of a SARS-CoV-2 variant with mutations L452R and N501Y in the spike protein

V. Beneš, T. Rausch, M. Boutros, 2021, medRxiv.

Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine Dose.

R. Bartenschlager, M. Zeier, P. Schnitzler, 2023, Transplantation.

Uptake, production and metabolism of cysteinyl leukotrienes in the isolated perfused rat liver. Inhibition of leukotriene uptake by cyclosporine.

W. Hagmann, I. Kaiser, S. Parthé, 1989, Biochemical Journal.